Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Rubinchik

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Vaccine|March 16, 2000
Recombinant expression and neutralizing activity of an MHC class II binding epitope of toxic shock syndrome toxin-1E Rubinchik, A W Chow
Life Sciences|January 1, 1996
Interleukin-2 inhibits 3T3 fibroblast proliferationE Rubinchik, F Levi-Schaffer
Israel Journal of Medical Sciences|July 1, 1995
Mast cell role in fibrotic diseasesF Levi-Schaffer, E Rubinchik
International Journal of Clinical & Laboratory Research|January 1, 1994
Mast cells and fibroblasts: two interacting cellsE Rubinchik, F Levi-Schaffer
The Journal of Investigative Dermatology|June 1, 1995
Activated mast cells are fibrogenic for 3T3 fibroblastsF Levi-Schaffer, E Rubinchik
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 1, 1994
Mast cell/fibroblast interactionsF Levi-Schaffer, E Rubinchik
Allergy|March 10, 1998
Responsiveness of human skin mast cells to repeated activation: an in vitro studyE Rubinchik, M Shalit, F Levi-Schaffer
International Journal of Immunopharmacology|July 1, 1995
Modulations of histamine release from mast cells by interleukin-2 is affected by nedocromil sodiumE Rubinchik, A Norris, F Levi-Schaffer
Cellular Immunology|May 1, 1995
Human foreskin mast cell viability and functional activity is maintained ex vivo by coculture with fibroblastsF Levi-Schaffer, R Kelav-Appelbaum, E Rubinchik
Experimental Hematology|March 1, 1997
Regulation of the functional activity of mast cells and fibroblasts by mononuclear cells in murine and human chronic graft-vs.-host diseaseF Levi-Schaffer, V Segal, V Barak, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Vaccine|March 16, 2000
Recombinant expression and neutralizing activity of an MHC class II binding epitope of toxic shock syndrome toxin-1E Rubinchik, A W Chow
Life Sciences|January 1, 1996
Interleukin-2 inhibits 3T3 fibroblast proliferationE Rubinchik, F Levi-Schaffer
Israel Journal of Medical Sciences|July 1, 1995
Mast cell role in fibrotic diseasesF Levi-Schaffer, E Rubinchik
International Journal of Clinical & Laboratory Research|January 1, 1994
Mast cells and fibroblasts: two interacting cellsE Rubinchik, F Levi-Schaffer
The Journal of Investigative Dermatology|June 1, 1995
Activated mast cells are fibrogenic for 3T3 fibroblastsF Levi-Schaffer, E Rubinchik
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 1, 1994
Mast cell/fibroblast interactionsF Levi-Schaffer, E Rubinchik
Allergy|March 10, 1998
Responsiveness of human skin mast cells to repeated activation: an in vitro studyE Rubinchik, M Shalit, F Levi-Schaffer
International Journal of Immunopharmacology|July 1, 1995
Modulations of histamine release from mast cells by interleukin-2 is affected by nedocromil sodiumE Rubinchik, A Norris, F Levi-Schaffer
Cellular Immunology|May 1, 1995
Human foreskin mast cell viability and functional activity is maintained ex vivo by coculture with fibroblastsF Levi-Schaffer, R Kelav-Appelbaum, E Rubinchik
Experimental Hematology|March 1, 1997
Regulation of the functional activity of mast cells and fibroblasts by mononuclear cells in murine and human chronic graft-vs.-host diseaseF Levi-Schaffer, V Segal, V Barak, et al.
Pageof 2